Montelukast Prescribing at PARK VIEW GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,323
Total Quantity
39.3K
NHS Cost
£1.9K
vs National Avg
+93.2%
PARK VIEW GROUP PRACTICE prescribed 1,323 items of Montelukast over the last 12 months at a cost of £1,927 to the NHS. This is 93.2% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
112
Jun 2026
88
Jun 2026
124
Jun 2026
96
Jun 2026
110
Jun 2026
107
Jun 2026
118
Jun 2026
113
Jun 2026
118
Jun 2026
105
Jun 2026
116
Jun 2026
116
Prescribing Details
| Total Items | 1,323 |
|---|---|
| Total Quantity | 39,254 |
| Total NHS Cost | £1,927 |
| Presentations | 4 different forms |
| vs National Average | +93.2% |
Montelukast Prescribing Comparison
| This practice | 1,323 items |
|---|---|
| National average per practice | 685 items |
| Difference | +93.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.